Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLBB.L Regulatory News (LBB)

  • There is currently no data for LBB

Grant of Options

24 Mar 2009 07:00

RNS Number : 3400P
Molectra Group Ltd
24 March 2009
Β 

ο»Ώ

Molectra Group Limited

(the "Company")

Grant ofΒ Share Options

The Company has adopted a newΒ shareΒ optionΒ scheme (the "Option Scheme") under which the Company has authority to grantΒ optionsΒ to any employee or director of, and any consultant to,Β the Company andΒ any ofΒ itsΒ subsidiariesΒ duringΒ prescribed grant periods. Pursuant to the Option Scheme the number of shares under option cannot exceed 10 per cent. of the Company's issued share capital as at the date of grant.Β 

TheΒ BoardΒ hasΒ yesterdayΒ resolvedΒ toΒ awardΒ options toΒ certainΒ directors and certain employeesΒ pursuant to the Option Scheme. The grants awarded to theΒ executiveΒ directors, which in aggregate are over 7,000,000 shares,Β areΒ set out in the table below.Β Β In addition to the options granted to theΒ executiveΒ directors, the Company hasΒ awardedΒ options overΒ 4,600,000 sharesΒ to non-board level employees. The first date on whichΒ theseΒ optionsΒ can be exercisedΒ isΒ 23Β March 2010Β (being the first anniversary of the date of the Board meeting which resolved to award the options)Β and theΒ final date onΒ which they can be exercised isΒ 23Β March 2019.

The Company also proposes, conditionally, to award options over a further 5,000,000 shares to non-executive directors and consultants. The grant ofΒ options to the non-executiveΒ directorsΒ and consultantsΒ is subject to consent being received from the Jersey Financial Services CommissionΒ to the grant of theΒ optionsΒ under the Control of Borrowing (Jersey) Order 1958Β and the CompanyΒ obtaining, by shareholder resolution at a subsequent date,Β authority toΒ allot the options. It is intended theseΒ optionsΒ will beΒ in all other respects identical to those granted to the executiveΒ directorsΒ and employees. A further announcement will be made when the grant ofΒ options to the non-executiveΒ directors becomes effective.

The options have beenΒ awardedΒ with an exercise price of 1.5 pence. This isΒ equal to the mid-market price as at the close of business on the last trading day before the date of grant and atΒ aΒ 50Β per cent. premium toΒ the price at which the last material market tradeΒ inΒ the Company's shares took place onΒ 4 February 2009Β and to the price of theΒ recently completedΒ share buyΒ back.

Grants to executive directors

Β 

Name
Number of shares under option
Exercise price per share
P. Gazzard
4,000,000
1.5p
R. Sargent
3,000,000
1.5p

Β 

Proposed grants to non-executive directors

Β 

Name
Number of shares under the proposed option
Proposed exercise price per share
W.R. King
1,000,000
1.5p
R.C. Maddock
1,000,000
1.5p
D. Hassum
1,000,000
1.5p

Apart from the aboveΒ options, the directors' interests in the Company's share capital remain unchanged and as previously disclosed.

The aggregate number of all the shares under option, including the sharesΒ that may be putΒ under option pursuant to the conditional awards to the non-executive directors and consultants, isΒ 16,600,000.

Β Β For further information please contact:

Molectra Group Limited

Paul Gazzard 01725 510 383

Rodger Sargent 020 7355 7660

Arbuthnot Securities Limited

Antonio Bossi 020Β 7012 2000

Threadneedle Communications Ltd

Graham HerringΒ  020 7653 9500

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSILFVAVEIVFIA
Date   Source Headline
20th Apr 20163:57 pmRNSDisposal Update
15th Apr 20167:00 amRNSDisposal Update
14th Apr 20167:00 amRNSResignation of Nomad
6th Apr 20167:00 amRNSDisposal Strategy Update
3rd Mar 20161:30 pmRNSDisposal Strategy and Suspension
3rd Mar 20161:30 pmRNSSuspension - Litebulb Group Limited
2nd Mar 201612:57 pmRNSRequisition of Extraordinary General Meeting
2nd Mar 20167:00 amRNSDisposal of Go Entertainment
22nd Feb 20167:00 amRNSFinancing Update
1st Feb 20167:00 amRNSFinancing Update
18th Jan 20167:00 amRNSTrading and Financing Update
9th Dec 201511:46 amRNSTrading update
2nd Nov 20157:00 amRNSLicence to sell Peppa Pig wooden toys
28th Oct 201510:00 amRNSDirectorate Change
30th Sep 20157:00 amRNSHalf Yearly Report
23rd Jul 20155:16 pmRNSHolding(s) in Company
16th Jul 20157:00 amRNSIssue of Equity
6th Jul 20157:00 amRNSBoard Appointments, Re-Organisation and updates
15th Jun 20155:36 pmRNSHolding(s) in Company
4th Jun 20155:07 pmRNSResult of AGM
18th May 20157:00 amRNSFinal Results
31st Mar 20159:17 amRNSIssue of Equity
27th Jan 20157:01 amRNSUpdate on acquisitions and trading
19th Jan 20157:00 amRNS$0.5m US orders for Star Wars homeware range
8th Jan 201512:33 pmRNSIssue of Equity
12th Dec 20142:32 pmRNSHolding(s) in Company
11th Dec 20148:57 amRNSCompletion of Acquisition
10th Dec 20142:24 pmRNSResult of EGM, Acquisition & Issue of Loan Notes
1st Dec 20147:00 amRNSHolding(s) in Company
13th Nov 20147:00 amRNSAcquisition
14th Oct 20147:00 amRNSContracts to supply Tesco and HMV
2nd Oct 20143:21 pmRNSIssue of Equity
30th Sep 20147:00 amRNSHalf Yearly Report
19th Sep 20147:00 amRNSLiteBulb Star Wars homeware range wins Award
8th Sep 20147:00 amRNSDeals with Epic Rights and Nickelodeon
22nd Jul 20147:00 amRNSGrant of Share Options
21st Jul 20147:00 amRNSOver £4m of orders signed with major retailers
2nd Jul 20147:00 amRNSGrant of Share Options
1st Jul 20147:00 amRNS£1m of Orders Signed with Major Retailers
27th Jun 20143:23 pmRNSIssue of Equity
16th May 20147:00 amRNSDirector/PDMR Shareholding
1st May 201412:26 pmRNSExercise of Options
23rd Apr 20144:05 pmRNSHolding(s) in Company
22nd Apr 201411:55 amRNSResult of AGM
11th Apr 20147:00 amRNSHolding(s) in Company
8th Apr 20147:00 amRNSIssue of Equity
7th Apr 20147:00 amRNSLaunch of new Terry O'Neill product range
2nd Apr 20147:01 amRNSProposed acquisition & issue of conv. loan notes
2nd Apr 20147:00 amRNSFinal Results
21st Mar 20149:45 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.